Stanford Medical School Shield
 
ARAMIS button
investigators button
research button
publications button
HAQ button
pharmaceutical collaborations button
 
Link to Main Stanford Medical School Site
 Heading Filler Publications Page Heading
Clear Spacer  
 

    1999

  • Albert D, Hurst S, Kallan M, Wolfe F, Fries J. The results of DMARD treatment on overall outcome of rheumatoid arthritis in a large cohort: sequence effects. Athritis Rhem. 1999;42:S216.
  • Albert D, Hurst S, Kallan M, Wolfe F, Fries J. The results of DMARD treatment on overall outcome of rheumatoid arthritis in a large cohort: Estimates of relative drug effectiveness. Arthritis Rheum. 1999;42:S71.
  • Beauchamp W, Stieber J, Kallan M, Hurst S, Fitzgerald R, Albert D. Who is a good candidate for THR? Developing a predictive model for the outcome of patients undergoing total hip replacement. Arthritis Rheum. 1999;42:S266.
  • Berard A, Solomon D, Wolfe F, Avorn J. Correlation between service utilization variables and activity and disability measures in rheumatoid arthritis. Arthritis Rheum. 1999;42:S71.
  • Buckland-Wright JC, Wolfe F, Ward RJ, Flowers N, Hayne C. Substantial superiority of semiflexed (MTP) views in knee osteoarthritis: a comparative radiographic study, without fluoroscopy, of standing extended, semiflexed (MTP), and schuss views. J Rheumatol. 1999;26(12):2664-74.
  • Clark A, Pierre YS, Joseph L, Penrod J, Sibley J. Radiographic damage correlations with functional disability in RA. Arthritis Rheum. 1999;42:S127.
  • Clarke AE, Levinton C, Joseph L, et al. Predicting the short term direct medical costs incurred by patients with rheumatoid arthritis. J Rheumatol. 1999;26(5):1068-75.
  • Fischer D, Stewart A, Bloch D, Lorig K, Laurent D, Holman H. Capturing the patient's view of change as a clinical outcome measure. JAMA. 1999;282:1157-62.
  • Fries J, Schettler J, Ramey D. Methotrexate and mortality in theumatoid arthritis (RA): Simpson paradox and other methodological problems. Arthritis Rheum. 1999;42:S135.
  • Fries JF. Safety, cost and effectiveness issues with disease modifying anti- rheumatic drugs in rheumatoid arthritis. Ann Rheum Dis. 1999;58 Suppl 1:I86-9.
  • Hawley D, Wolfe F, Pincus T. Use of combination therapy in the routine care of patients with rheumatoid arthritis: physician and patient surveys. Clinical and Experimental Rheumatology. 1999;17:S78-82.
  • Hubert H, Bloch D, Oehlert J, Fries J. Life-style habits and compression of morbidity. Arthritis Rheum. 1999;42:S223.
  • Katz P, Lubeck D, Wanke L, Buatti M. Determinants of RA patients' global health status ratings. Arthritis Rheum. 1999;42:S286.
  • Keysor J, Pincus T, Callhan L, Curry S. Associations of lower extremity joints with 25-foot walk time. Arthritis Rheum. 1999;42:S286.
  • Lane N, Nevitt N, Williams E, Cummings S, Hochberg M. The association of nitrate use and incident radiographic hip OA in older white women. Arthritis Rheum. 1999;42:S165.
  • Lorig K, Gonzalez VM, Ritter P. Community-based Spanish language arthritis education program: a randomized trial. Med Care. 1999;37(9):957-63.
  • Lorig K, Laurent D. Lessons learned on the way to the information highway: a randomized trial. Arthritis Rheum. 1999;42:S110.
  • Lorig K, Sobel D, Stewart A. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized trial. Medical Care. 1999;37:5-14.
  • Manek N, Chong M, Fries J, Lane N. Longitudinal progression of radiographic hand osteoarthritis. Arthritis Rheum. 1999;42:S297.
  • Peloso P, Ashworth N, al MRe. A titrated dose vs. full dose misoporstol in the prevention of NSAID gastropathy: A randomized control trial. Arthritis Rheum. 1999;42:S74.
  • Pincus T, Breedveld FC, Emery P. Does partial control of inflammation prevent long-term joint damage? Clinical rationale for combination therapy with multiple disease- modifying antirheumatic drugs. Clin Exp Rheumatol. 1999;17(6 Suppl 18):S2-7.
  • Pincus T, Brooks RH, Callahan LF. A proposed 30-45 minute 4 page standard protocol to evaluate rheumatoid arthritis (SPERA) that includes measures of inflammatory activity, joint damage, and longterm outcomes. J Rheumatol. 1999;26(2):473-80.
  • Pincus T, Callahan L, Keysor J. Evidence-based predictors of mortality over 10 years in rheumatoid arthritis: Age, comorbidity, male sex, poor functional status, and rheumatoid factor. Arthritis Rheum. 1999;42:S131.
  • Pincus T, O'Dell JR, Kremer JM. Combination therapy with multiple disease-modifying antirheumatic drugs in rheumatoid arthritis: a preventive strategy. Ann Intern Med. 1999;131(10):768-74.
  • Pincus T, Stein C. Patients with Rheumatoid Arthritis (RA) who have 6 or more swollen or tender joints are more likely to have damaged joints compared to those with fewer than 6 swollen or tender joints. Arthritis Rheum. 1999;42:S241.
  • Pincus T, Stein CM. ACR 20: clinical or statistical significance? Arthritis Rheum. 1999;42(8):1572-6.
  • Pincus T, Swearingen C. Do clinical trials in rheumatoid arthritis (RA) select for "non-respondent" patients? Comparisons of earlier courses of patients with 6 or more versus fewer than 6 swollen or tender joints. Arthritis Rheum. 1999;42:S350.
  • Pincus T, Swearingen C, Wolfe F. Toward a multidimensional Health Assessment Questionnaire (MDHAQ): assessment of advanced activities of daily living and psychological status in the patient-friendly health assessment questionnaire format. Arthritis Rheum. 1999;42(10):2220-30.
  • Ramey D, Rausch P, Schettler J, Singh G. Serious infections in rheumatoid arthritis : What is the scope of the problem? Arthritis Rheum. 1999;42:S279.
  • Schettler J, Wong J, Ramey D, Singh G. Prednisone use significantly increases the risk of hip fractures in rheumatoid arthritis. Arthritis Rhem. 1999;42:S136.
  • Schwartz AV, Villa ML, Prill M, et al. Falls in older Mexican-American women. J Am Geriatr Soc. 1999;47(11):1371-8.
  • Singh G, Ramey D, Rausch P, Schettler J. Serious infections in rheumatoid arthritis: Relationship to immunosuppressive use. Arthritis Rheum. 1999;42:S42.
  • Singh G, Ramey D, Triadafilopoulos G. Early Experience with selective COX-2 inhibitors: Safely profile in over 340,000 patinet years of use. Arthritis Rheum. 1999;42:S296.
  • Singh G, Triadafilopoulos G. Epidemiology of NSAID induced gastrointestinal complications. J Rheumatol. 1999;26 Suppl 56:18-24.
  • Steen V, Medsger T. Survival of patients with systemic and scleroderma specific autoantibodies. Arthritis Rheum. 1999;42:S189.
  • Steen V, Medsger T. Risk factors for the development of isolated pulmonary hypertension (PHT) in systemic sclerosis (SSC). Arthritis Rheum. 1999;42:S189.
  • Steen VD, Medsger TA, Jr. Fertility and pregnancy outcome in women with systemic sclerosis. Arthritis Rheum. 1999;42(4):763-8.
  • Stein CM, Pincus T. Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate. Clin Exp Rheumatol. 1999;17(6 Suppl 18):S47-52.
  • Stein CM, Pincus T. Placebo-controlled studies in rheumatoid arthritis: ethical issues. Lancet. 1999;353(9150):400-3.
  • Tennant A, Ryser L, Stucki G, Wolfe F. An 8-item international version of the HAQ: The inter-HAQ. Arthritis Rheum. 1999;42:S74.
  • Wang B, Fries J. Area under the curve (AUC) as a model of cummulative disability in rheumatoid arthritis. Arthritis Rheum. 1999;42:S219.
  • Wang B, Ramey D, Fries J. Postponed development of disability in senior runners: A controlled 13-year longitudinal study. Arthritis Rheum. 1999;42:S74.
  • Wang B, Wolfe F, Fries J. Reduction in cummulative disability with increasing exposure to methotrexate in rheumatoid arthritis. Arthritis Rheum. 1999;42:S380.
  • Ward MM. Provision of primary care by office-based rheumatologists: results from the National Ambulatory Medical Care Surveys, 1991-1995. Arthritis Rheum. 1999;42(3):409-14.
  • Ward MM. Hospital experience and mortality in patients with systemic lupus erythematosus. Arthritis Rheum. 1999;42(5):891-8.
  • Ward MM. Trends in the use of disease modifying antirheumatic medications in rheumatoid arthritis, 1980-1995: results from the National Ambulatory Medical Care Surveys. J Rheumatol. 1999;26(3):546-50.
  • Ward MM, Donald F. Pneumocystis carinii pneumonia in patients with connective tissue diseases: the role of hospital experience in diagnosis and mortality. Arthritis Rheum. 1999;42(4):780-9.
  • Ward MM, Kuzis S. Validity and sensitivity to change of spondylitis-specific measures of functional disability. J Rheumatol. 1999;26(1):121-7.
  • Wolfe F. Determinants of WOMAC function, pain and stiffness scores: evidence for the role of low back pain, symptom counts, fatigue and depression in osteoarthritis, rheumatoid arthritis and fibromyalgia. Rheumatology (Oxford). 1999;38(4):355-61.
  • Wolfe F. Psychological distress and rheumatic disease. Scand J Rheumatol. 1999;28(3):131-6.
  • Wolfe F, Hawley D. Characteristics of patients beginning a newly released DMARD: Expected response and patient selection. Arthritis Rheum. 1999;42:S75.
  • Wolfe F, Hawley D, Anderson J. All cause and cause specific mortality in rheumatoid arthritis (RA): A 25-year study of 1, 865 patients. Arthritis Rheum. 1999;42:S135.
  • Wolfe F, Hawley D, Anderson J. Inflammation as measured by the ESR predicts cardiovascular mortality across all rheumatic disorders: A 25 year prospective study of 5,822 patients. Arthritis Rheum. 1999;42:S299.
  • Wolfe F, Hawley D, Pincus T. Standard values for self-report questionnaires: Assessment in 20,574 rheumatic disease patients. Arthritis Rheum. 1999;42:S75.
  • Wolfe F, Kon S. A quetionnaire-based disease activity scale (q-das) for rheumatoid arthritis: Relationship with health-related quality of life (QOL). Arthritis Rheum. 1999;42:S134.
  • Wolfe F, Kong SX. Rasch analysis of the Western Ontario MacMaster questionnaire (WOMAC) in 2205 patients with osteoarthritis, rheumatoid arthritis, and fibromyalgia. Ann Rheum Dis. 1999;58(9):563-8.
  • Wolfe F, Lane N. The longterm outcomes of Knee OA: Rates of radiographic progression in clinical OA patients followed for up to 26 years. Arthritis Rheum. 1999;42:S147.
  • Wolfe F, Lane N, Buckland-Wright C. Radiographic methods in knee OA are not the same: Superiority of the MTP view in detecting joint space narrowing in the clinic. Arthritis Rheum. 1999;42:S296.
  • Wolfe F, Newman S. Psychological factord present at disease onset predict subsequent improvement: The US inception cohort study. Arthritis Rheum. 1999;42(9):S352.
  • Wolfe F, Pincus T. Listening to the patient: a practical guide to self-report questionnaires in clinical care. Arthritis Rheum. 1999;42(9):1797-808.
  • Wolfe MM, Lichtenstein DR, Singh G. Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs. N Engl J Med. 1999;340(24):1888-99.
 

ARAMIS |  Investigators |  Research |  Publications |  HAQ |  Pharmaceutical Collaborations

©2001 Stanford University. All Rights Reserved. If you experience any difficulty with this site, please email our webmaster. Last updated October 2001.